Filamentous fungi produce a vast universe of secondary metabolites (SM) with biological activities that are of central importance for progress in medicine and agriculture. For example, fungal SMs exhibit cytostatic, immunosuppressant, lipid lowering, or antimicrobial properties. Rapid progress in sequencing the genomes of filamentous fungi has revealed a very large number of putative biosynthetic pathways with no known metabolites, suggesting a vast potential for the discovery of new compounds and activities. However, significant impediments to full characterization of fungal BGC diversity exist: (a) many SMs are synthesized by ?non-canonical? biosynthetic gene clusters (BGCs) not recognized by bioinformatic algorithms, (b) many BGCs are not expressed in standard laboratory conditions (e.g. ?cryptic? BGCs), and (c) genes for some biosynthetic pathways are not all clustered and involve more than one locus. Further, there is (d) little understanding of the genesis of functional BGCs. Our recent results clearly indicate that non-canonical BGCs reveal genuinely novel structures or unusual biochemistry, that specific fungal differentiation signals induce global BGC expression and that ?hot spots? of recombination generate BGC diversity. In this grant, we will (i) characterize isocyanide synthase (ICS) BGCs, a recently discovered family of noncanonical fungal BGCs not recognized by current software algorithms for which we have preliminary results demonstrating new and exciting biochemistry, (ii) use a fungal differentiation signal for transcriptomic identification of ?invisible' BGCs across diverse fungal taxa and (iii) address the hypothesis that genomic ?hot spots? of recombination and horizontal transfer give birth to new BGCs. Based on the premise that non-canonical gene clusters are particularly likely to produce chemical entities with a high degree of structural and functional novelty coupled with two advances able to identify active BGCs and how BGC are formed, our tool set of comparative transcriptomics, advanced endogenous and heterologous expression platforms and a recently developed platform for comparative metabolomics will provide a wealth of new structures, biosynthetic pathways, and biological activities through expansion of the biology, genetics and chemistry of fungal BGCs. Moreover, insight into BGC genesis and identification of global BGC induction signals present genuinely new processes to further the scope of fungal BGC discovery and functional annotation.

Public Health Relevance

/ PUBLIC HEALTH STATEMENT Fungal natural products or secondary metabolites (SMs) have been invaluable as platforms for developing front-line drugs. Many putative SMs have remained undiscovered because current methodologies often fail to detect the genes involved in their production. This work will advance methods for discovery of useful SMs and provide a functional blueprint for identifying fungal SMs.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Bond, Michelle Rueffer
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
Schools of Medicine
United States
Zip Code
Spraker, Joseph E; Wiemann, Philipp; Baccile, Joshua A et al. (2018) Conserved Responses in a War of Small Molecules between a Plant-Pathogenic Bacterium and Fungi. MBio 9:
Khalid, Saima; Baccile, Joshua A; Spraker, Joseph E et al. (2018) NRPS-Derived Isoquinolines and Lipopetides Mediate Antagonism between Plant Pathogenic Fungi and Bacteria. ACS Chem Biol 13:171-179
O'Neill, Erinn M; Mucyn, Tatiana S; Patteson, Jon B et al. (2018) Phevamine A, a small molecule that suppresses plant immune responses. Proc Natl Acad Sci U S A 115:E9514-E9522
Pfannenstiel, Brandon T; Greco, Claudio; Sukowaty, Andrew T et al. (2018) The epigenetic reader SntB regulates secondary metabolism, development and global histone modifications in Aspergillus flavus. Fungal Genet Biol 120:9-18
Lim, Fang Yun; Won, Tae Hyung; Raffa, Nicholas et al. (2018) Fungal Isocyanide Synthases and Xanthocillin Biosynthesis in Aspergillus fumigatus. MBio 9:
Pfannenstiel, Brandon T; Zhao, Xixi; Wortman, Jennifer et al. (2017) Revitalization of a Forward Genetic Screen Identifies Three New Regulators of Fungal Secondary Metabolism in the Genus Aspergillus. MBio 8:
Baccile, Joshua A; Spraker, Joseph E; Le, Henry H et al. (2016) Plant-like biosynthesis of isoquinoline alkaloids in Aspergillus fumigatus. Nat Chem Biol 12:419-24
McClure, Ryan A; Goering, Anthony W; Ju, Kou-San et al. (2016) Elucidating the Rimosamide-Detoxin Natural Product Families and Their Biosynthesis Using Metabolite/Gene Cluster Correlations. ACS Chem Biol 11:3452-3460
Macheleidt, Juliane; Scherlach, Kirstin; Neuwirth, Toni et al. (2015) Transcriptome analysis of cyclic AMP-dependent protein kinase A-regulated genes reveals the production of the novel natural compound fumipyrrole by Aspergillus fumigatus. Mol Microbiol 96:148-62
Wever, Walter J; Bogart, Jonathan W; Baccile, Joshua A et al. (2015) Chemoenzymatic synthesis of thiazolyl peptide natural products featuring an enzyme-catalyzed formal [4 + 2] cycloaddition. J Am Chem Soc 137:3494-7

Showing the most recent 10 out of 11 publications